Grayanotoxane-3,5,6,10,14,16-hexol

HCID 207666CAS 30460-38-9
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

Standard-SMILES
CC1(C)[C@H](O)C[C@H]2[C@](C)(O)[C@@H]3CCC4[C@H](O)C3(C[C@@H](O)[C@@]21O)C[C@@]4(C)O
InChIKey
BWMFRQKICHXLSH-PMDFNMFYSA-N
Summenformel
C20H34O6
Durchschnittliche Molmasse
370,5 g/mol
Monoisotopische Masse
370,23553881

Überblick

Grayanotoxins are toxins found in rhododendrons and other plants of the family Ericaceae. It can be found in honey made from their nectar and cause a very rare poisonous reaction called grayanotoxin poisoning, honey intoxication, or rhododendron poisoning. (L1251)

Namen und Bezeichner

Bevorzugter Name
Grayanotoxane-3,5,6,10,14,16-hexol
IUPAC
(3R,4R,6R,8S,9R,10R,14R,16S)-5,5,9,14-tetramethyltetracyclo[11.2.1.01,10.04,8]hexadecane-3,4,6,9,14,16-hexol

Namen und Synonyme

DTXSID80952790Grayanotoxane-3,5,6,10,14,16-hexol30460-38-9RefChem:1086182DTXCID5013808643-Epigrayanotoxin III3-epi-Grayanotoxin III(3-alpha,6-beta,14R)Grayanotoxane-3,5,6,10,14,16-hexolGrayanotoxane-3,5,6,10,14,16-hexol, (3-alpha,6-beta,14R)-(14S)-Grayanotoxane-3alpha,5,6beta,10,14,16-hexol

Datenbank-Bezeichner

CAS
30460-38-9
PubChem CID
207666
DTXSID
DTXSID80952790

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,3
Polarare Oberfläche (TPSA)
121 Ų
H-Brücken-Donoren
6
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
0
Schwere Atome
26

Sicherheit und Regulatorisches

Toxikologische Informationen

TreatmentMedical treatment is not often needed but sometimes atropine therapy, vasopressors and other agents are used to mitigate symptoms. (L1251)
Health EffectsGrayanotoxins affect the nervous system but are not usually fatal. (L1251)
Exposure RoutesOral (ingestion) (L1817) ; dermal (L1817)
Toxicity SummaryGrayanotoxins bind to specific sodium ion channels in cell membranes. The grayanotoxins prevent inactivation, leaving excitable cells depolarized. (L1251)
Signs and Symptoms · 1 Eintrag

Initial symptoms include excessive salivation, perspiration, vomiting, dizziness, weakness and paresthesia in the extremities and around the mouth, low blood pressure and sinus bradycardia. In higher doses symptoms can include loss of coordination, severe and progressive muscular weakness, bradycardia (and, paradoxically, ventricular tachycardia), and nodal rhythm or Wolff-Parkinson-White syndrome. (L1251)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Chemie und Industrie

Verwendung und Herstellung

UsesGrayanotoxins are toxins found in rhododendrons and other plants of the family Ericaceae. (L1251)

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen

Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.

Verknüpfte Notizen

Wird geladen…